Search

everythinglearnresearchcommunity

for

Search:↓

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Genomic approach finds new possible treatments for hair loss.

Non-obese women with hair loss have higher heart disease risk.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

675 nm laser therapy effectively improves hair growth and density in AGA patients.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

The testes significantly contribute to vitamin D metabolism and may affect male reproductive health and conditions like hair loss.

Higher fasting insulin levels increase the risk of androgenetic alopecia.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

675 nm laser therapy effectively improves hair growth in Indian patients with androgenetic alopecia.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Low-dose oral minoxidil is safe and effective for treating hair loss, with most side effects being mild and reversible.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

A young Persian cat had a skin infection and low platelets, treated with various medications.

Hair loss caused by genetics and hormones; more research needed for treatments.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Most children with MIS-C showed significant improvement by 6 months.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Higher levels of certain proteins may increase or decrease rosacea risk.

A genetic variant in the GJB6 gene likely caused the Labrador's paw pad condition.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

CD44 variant changes start alopecia areata, but don't maintain it.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

IBD treatment is complex and requires personalized approaches due to varying patient responses.